- Home
- REE vs ZNTL Comparison
REE vs ZNTL Comparison
Compare REE & ZNTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REE
- ZNTL
- Stock Information
- Founded
- REE 2011
- ZNTL 2014
- Country
- REE Israel
- ZNTL United States
- Employees
- REE N/A
- ZNTL N/A
- Industry
- REE Auto Manufacturing
- ZNTL Biotechnology: Pharmaceutical Preparations
- Sector
- REE Consumer Discretionary
- ZNTL Health Care
- Exchange
- REE Nasdaq
- ZNTL Nasdaq
- Market Cap
- REE 115.5M
- ZNTL 137.9M
- IPO Year
- REE N/A
- ZNTL 2020
- Fundamental
- Price
- REE $2.66
- ZNTL $1.63
- Analyst Decision
- REE Strong Buy
- ZNTL Buy
- Analyst Count
- REE 2
- ZNTL 8
- Target Price
- REE $14.50
- ZNTL $8.53
- AVG Volume (30 Days)
- REE 195.1K
- ZNTL 852.5K
- Earning Date
- REE 04-29-2025
- ZNTL 03-26-2025
- Dividend Yield
- REE N/A
- ZNTL N/A
- EPS Growth
- REE N/A
- ZNTL N/A
- EPS
- REE N/A
- ZNTL N/A
- Revenue
- REE $626,000.00
- ZNTL $67,425,000.00
- Revenue This Year
- REE N/A
- ZNTL N/A
- Revenue Next Year
- REE $21,460.67
- ZNTL N/A
- P/E Ratio
- REE N/A
- ZNTL N/A
- Revenue Growth
- REE N/A
- ZNTL N/A
- 52 Week Low
- REE $2.40
- ZNTL $1.58
- 52 Week High
- REE $11.72
- ZNTL $16.27
- Technical
- Relative Strength Index (RSI)
- REE 19.22
- ZNTL 36.50
- Support Level
- REE $5.66
- ZNTL $1.78
- Resistance Level
- REE $4.01
- ZNTL $2.02
- Average True Range (ATR)
- REE 0.60
- ZNTL 0.15
- MACD
- REE -0.16
- ZNTL -0.00
- Stochastic Oscillator
- REE 6.19
- ZNTL 3.53
About REE REE Automotive Ltd.
REE Automotive Ltd is an automotive technology company focused on building commercial electric vehicles controlled fully by-wire. The company is developing REEcorner technology which packs critical vehicle components into a single compact module positioned between the chassis and the wheel as well as building commercial Electric Vehicles (EV) leveraging REEcorner technology. The company has geographical preference in Israel, Germany, United States, United Kingdom, and other regions.
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. It uses a drug discovery engine, which it refers to as an Integrated Discovery Engine, to identify targets and develop small molecule new chemical entities, or NCEs, with properties that it believes could result in potentially differentiated product profiles. It has two lead product candidates under pipeline: ZN-c5, for the treatment of advanced estrogen receptor-positive, human epidermal growth factor receptor 2-negative, or ER+/HER2-, advanced or metastatic breast cancer; and ZN-c3, for the treatment of advanced solid tumors as monotherapy and ovarian cancer.